• Login
    View Item 
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • GRASP: Graduate Research and Scholarly Projects
    • Proceedings 2007: 3rd Annual Symposium: Graduate Research and Scholarly Projects
    • View Item
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • GRASP: Graduate Research and Scholarly Projects
    • Proceedings 2007: 3rd Annual Symposium: Graduate Research and Scholarly Projects
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Serum selenium and the risk of prostate cancer

    View/Open
    Conference paper (147.6Kb)
    Date
    2007-04-27
    Author
    Stancoff-Hon, Chelsea
    Carter, John W.
    Metadata
    Show full item record
    Citation
    Stancoff-Hon, Chelsea & Carter, John.(2007).Serum selenium and the risk of prostate cancer. In Proceedings : 3rd Annual Symposium : Graduate Research and Scholarly Projects. Wichita, KS : Wichita State University, p.139-140
    Abstract
    Introduction: The purpose of this study is to investigate the relationship of serum selenium levels and the risk of developing prostate cancer. It has been documented that antioxidants reduce the incidence of cancer by eradicating free radicals that damage DNA, thus increasing the risk of cancer. Selenium is a component of the antioxidant enzyme glutathione peroxidase, whose role in cancer prevention has been controversial in the last 40 years. Methodology: A systematic review of evidence-based literature was performed utilizing the following search engines: MEDLINE FirstSearch, ArticleFirst, dissertations, and Paper’s First and a bibliographic search of selected articles. MeSH ( medical subject heading terms) and text words utilized in this study include: serum, selenium, prostate, neoplasia, risk, nutrition, adenocarcinoma, male, prostatic intraepithelial neoplasm, and prostatic neoplasia. Results: The results of the evidence-based literature results are consistent with the epidemiologic studies available at this time. The best quality evidence suggests that higher selenium levels decrease a man’s risk of developing prostate cancer. However, because of unaccounted for confounders including family history of prostate cancer and educational level, it is not recommended that providers prescribe selenium as preventive medicine combating prostate cancer. Nevertheless, individuals who have a higher intake of selenium may benefit from its protective effects
    Description
    Paper presented to the 3rd Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at the Hughes Metropolitan Complex, Wichita State University, April 27, 2007.

    Research completed at the Department of Physician Assistant, College of Health Professions
    URI
    http://hdl.handle.net/10057/831
    Collections
    • PA Graduate Student Conference Papers
    • Proceedings 2007: 3rd Annual Symposium: Graduate Research and Scholarly Projects

    Browse

    All of Shocker Open Access RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsBy TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace software copyright © 2002-2023  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV